Apollomics, Inc. (NASDAQ:APLMW) Short Interest Update

Apollomics, Inc. (NASDAQ:APLMW) saw a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 53,800 shares, a decrease of 17.2% from the October 15th total of 65,000 shares. Based on an average daily volume of 22,000 shares, the short-interest ratio is presently 2.4 days.

Apollomics Stock Performance

NASDAQ APLMW opened at $0.01 on Friday. Apollomics has a 12-month low of $0.01 and a 12-month high of $0.06. The company has a 50 day moving average price of $0.01 and a two-hundred day moving average price of $0.01.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.